Edition:
India

Profile: Ajanta Pharma Ltd (AJPH.BO)

AJPH.BO on Bombay Stock Exchange

1,535.90INR
30 May 2016
Change (% chg)

Rs6.85 (+0.45%)
Prev Close
Rs1,529.05
Open
Rs1,529.00
Day's High
Rs1,555.20
Day's Low
Rs1,529.00
Volume
8,401
Avg. Vol
18,962
52-wk High
Rs1,720.00
52-wk Low
Rs1,103.00

Ajanta Pharma Limited is a pharmaceutical company engaged in development, research, manufacture and marketing of dosages in domestic and international markets. Ajanta operates with five manufacturing facilities, four in India and one in Mauritius that produce pharmaceutical products. It is engaged in commercializing generic products and combination products in the therapeutic areas of anti-malarial, cardiovascular, dermatology, male erectile dysfunction, musculoskeletal and ophthalmology. Its manufacturing capabilities include a range of dosage forms of allopathic drugs, including tablets, capsules, ointments, injections and dry powder. Its key products include the brand called Kamagra, for the treatment of Male Erectile Dysfunction (MED) and Artefan, for the treatment of malaria. The Companies subsidiaries include Ajanta Pharma (Mauritius) Limited, Ajanta Pharma USA Inc., and Ajanta Pharma Philippines Inc.

Company Address

Ajanta Pharma Ltd

Gnanananda Place, Kalapet
MUMBAI     400067
P: +9122.66061000
F: +9122.66061200

Company Web Links